Enter a keyword to search
Abstracts for 2009 Meeting
48th  ANNUAL SCIENTIFIC MEETING21-24 October 2009Congress CentrePiazza Adua
Abstracts for 2008 Meeting
Posters Workshops Oral
Abstracts for 2007 Meeting
'A Global Spinal Cord Injury Conference' 27 June - 1 July 46th ISCoS Annual Scie
Abstracts for 2006 Meeting
ISCoS'A Global Spinal Cord Injury Conference'25-28 June 2006:45th ISCoS
Abstracts for 2005 Meeting
ISCoS44th Annual Scientific Meeting4th - 8th October 2005Munich and Murn
Abstracts for 2004 Meeting
ABSTRACTS for 2004 meeting     ORAL PRESENTATIONS
We apologise to our members who are experiencing problems with accessing the Members Only Section.

If you are unable to login, please contact us with your details.
Username: Password:

Abstracts - Abstracts for 2004 Meeting

ABSTRACTS for 2004 meeting

 

  ORAL PRESENTATIONS
O01 Typical gait patterns in patients with incomplete spinal cord injury: assessment with 3D gait analysis
O02 DIAGNOSTIC SYMPTOMS OF SCI-PATIENTS WITH SYRINGOMYELIA
O03 Influence of spasticity on bone parameters of lower extremities in spinal cord injury
O04 Active Cycling in incomplete spastic paraplegia during primary rehabilitation: Time profile of pathological muscle activation pattern
O05 FUNCTIONAL OUTCOMES FOLLOWING BOTULINUM TOXIN IN SPINAL CORD INJURY
O06 ANTISPASTIC EFFECT OF PENILE VIBRATION IN SPINAL CORD LESIONED MEN
O07 SURGICAL TREATMENT OF PAINFUL SPASTICITY AFTER SPINAL CORD INJURY
O08 THE EFFECT OF PENILE VIBRATORY STIMULATION ON SPASTICITY IN SPINAL CORD INJURED MEN
O09 Managing SCI: The First 72 Hours
O10 Prevention of venous thromboembolism in the acute phase after spinal cord injury: a randomized multicentre trial comparing low-dose heparin plus intermittent pneumatic compression with enoxaparin
O11 Prevention of venous thrombo-embolism in the rehabilitation phase after spinal cord injury (SCI): prophylaxis with low-dose heparin or enoxaparin
O12

Determining the duration of anticoagulation in patients with spinal cord injury at risk for venous thrombo-embolism
O13 Blockage of interleukine-6 receptor ameliorates functional recovery in spinal cord injury 
O14 PROTOCOL OF SCREENING AND NUTRITIONAL ASSESSMENT IN PATIENTS WITH SPINAL CORD INJURY (SCI)
O15 Spinal Cord injury registry for cervical spinal cord injuries in New South Wales Rugby Union and Rugby League players who have suffered permanent neurological deficit
O16 DEVELOPMENT OF AN EVIDENCE-BASED WHEELCHAIR PRESENTER PROGRAM IN SCHOOLS TO ADDRESS RISK-TAKING AND INJURY PREVENTION  
O17 Quality of life of people with spinal cord injuries: a comparative study of three community samples.
O18 Health Status, Community Integration and Economic Risk Factors for Mortality After Spinal Cord Injury
O19 Factors predicting quality of life among people with long-term spinal cord injury
O20 Life after Spinal Cord Injury: Ranked Priorities Identified by British Columbians with SCI living in the Community
O21 Urinary calculi following traumatic spinal cord injury
O22 Environmental Factors and Their Role in Participation and Life Satisfaction After Spinal Cord Injury
O23 Physical Activity and Fitness: Priorities Identified by Persons Living with Spinal Cord Injury
O24 Cardiovascular disease and risk factors among individuals with chronic spinal cord injury
O25 NEUROGENIC DETRUSOR OVERACTIVITY IN SPINAL CORD INJURIED (SCI) PATIENTS: FIVE YEARS EXPERIENCE USING ENGLISH BOTULINUM-TOXIN-A TREATMENT
O26 Spinal-Injured Neuropathic Bladder Antisepsis (SINBA) Trial
O27 EFFECTS OF BOTULINUM TOXIN INJECTION IN THE DETRUSOR MUSCLE OF PATIENTS WITH SPINAL INJURIES ON URETERIC REFLUX
O28 CORRELATION BETWEEN NEUROLOGICAL DATA, BLADDER MANAGEMENT AND URODYNAMIC FUNCTION IN TRAUMATIC SPINAL CORD INJURED PATIENTS
O29 Impacts of Functional Improvement after Olfactory Ensheathing Cells Transplantation for Chronic Spinal Cord Injury
O30 PERRUIN-VERBE
O31 A longitudinal evaluation of sleep and breathing following cervical spinal cord injury
O32 Treatment of bowel dysfuction in patients with spinal cord injuries/diseases with Macrogol 3350 plus electrolytes (Movicol®) 
O33 Epidemiology of Methicillin-Resistant Staphylococcus aureus (MRSA) in a national spinal cord injury center: A 10 years’ prospective study including molecular typing
O34 High prevalence of incontinence in adolescents with spina bifida
O35 Renal function and morphology in adults with meningomyelocele
O36 LONGSTANDING PAIN IN ADULTS WITH SPINA BIFIDA 
O37 Ambulation in adult spina bifida (SB). Is it possible to predict the level of ambulation in early life
O38 Social and personal life outcome for adults with Spina Bifida
O39 Relationships and sex life in young adults with spina bifida
O40 MOBILITY AIDS AND TRANSPORT POSSIBILITIES 10-45 YEARS AFTER SPINAL CORD INJURY (SCI)
O41 VOLUNTARY MOVEMENTS IN SPITE OF COMPLETE SPINAL CORD INJURY  
O42 DEVELOPMENT OF A METHODOLOGY FOR THE FUNCTIONAL EVALUATION OF DISABLED DRIVERS
O43 Walking and other functions preference in spinal cord injury patients: consumers vs. professionals
O44 Motor Recovery, Functional Status and Health Related Quality of Life in Complete Spinal Cord Injuries (CSCI)
O45 Pain in People with Long Standing Spinal Cord Injury
O46 SURVEY OF THE USE OF STANDING APPARATUS – IMPACT OF ORTHOSTATIC HYPOTENSION SECONDARY TO SPINAL CORD INJURY
O47 Quality of life measurements among male Israeli paraplegics
O48 Long term urological outcome of paediatric spinal cord injury
O49 Reliability Levels of the ASIA Motor and Sensory Examination in Physician versus Physical Therapist Examiners
O50 Accuracy of ASIA Impairment Scale of Spinal Cord Injury Using the 2002 Standards
O51 Neurological and functional outcome in patients with traumatic central cord syndrome
O52 Perceptual threshold to cutaneous electrical stimulation in patients with spinal cord injury
O53 Advantages of Phrenic Nerve Stimulation Treatment for patients with high-levelled tetraplagia
O54 RELIABILITY AND VALIDITY OF DANISH TETRAPLEGIA HAND FUNCTION TEST IN A FOUR COUNTRY MULTICENTER STUDY
O55 Prospective Validity and Responsiveness to Change of the Walking Scale for Spinal Cord Injury (WISCI) in a Randomized Clinical Trial
O56 Psychometric Analysis of a Clinically Focussed Measure of Outcome: The Needs Assessment Checklist (NAC)
O57 A Longitudinal Analysis of Psychological Impact , Coping Strategies and Post Traumatic Psychological growth following SCI: The First Ten Years
O58  Neuropsychological complications in and treatment of patients with a severe degree of tetraplegia – outcome measures
O59 Comparison between fetal spinal cord-and forebrain-derived neural stem/progenitor cells as a source of transplantation for spinal cord injury
O60  Flaccid paraplegia following proliferation of intrathecally administered fetal stem cells
O61  In Vitro Investigation Of Heat Transfer In Calf Spinal Cord During Polymethylmethacrylate Application For Vertebral Body Reconstruction
O62 ACONTRACTILE DETRUSOR IN SUPRASACRAL SPINAL CORD LESION
O63 SERUM CYSTATIN C AS A MARKER OF RENAL FUNCTION IN PATIENTS WITH SPINAL CORD INJURY
O64 Autonomic Disreflexia: Provokative Testing For Early Diagnosis and Management
O65 Sweating Response in Patients with Spinal Cord Injury
O66 Vascular Changes in Spinal Cord Injured Individuals After 4 Weeks Training With a Hybrid FES-Cycle Ergometer
O67 BWS therapy for spinal cord injury patients: backward and in place stepping
O68 SEXUAL AND AFFECTIVE LIFE DURING AND AFTER REHABILITATION: FROM MEDICAL TO PSYCHOLOGICAL APPROACH
O69 A model for combined bladder emptying and neuromodulation using independent anterior and posterior sacral nerve stimulation 
O70 Medical Complications vis-à-vis Psychosocial complications in SCI patient: A case Report
O71 Complementary (non-pharmacological) pain relieving therapies in spinal cord injured individuals: a patient perspective
O72 Mortality and causes of death after traumatic spinal cord injury in Norway – 1961-2002
O73 Heterotopic ossification in patients with traumatic medullar injury: association with HLA-system antigens
O74 False positive results of procalcitonin measurements in patients with paraplegia or quadriplegia